These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23931849)

  • 1. Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancer.
    Kawakami M; Ishikawa R; Amano Y; Sunohara M; Watanabe K; Ohishi N; Yatomi Y; Nakajima J; Fukayama M; Nagase T; Takai D
    Cancer Sci; 2013 Nov; 104(11):1447-54. PubMed ID: 23931849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FER overexpression is associated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer.
    Kawakami M; Morita S; Sunohara M; Amano Y; Ishikawa R; Watanabe K; Hamano E; Ohishi N; Nakajima J; Yatomi Y; Nagase T; Fukayama M; Takai D
    Int J Clin Exp Pathol; 2013; 6(4):598-612. PubMed ID: 23573306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fer protein-tyrosine kinase promotes lung adenocarcinoma cell invasion and tumor metastasis.
    Ahn J; Truesdell P; Meens J; Kadish C; Yang X; Boag AH; Craig AW
    Mol Cancer Res; 2013 Aug; 11(8):952-63. PubMed ID: 23699534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BARD1: an independent predictor of survival in non-small cell lung cancer.
    Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
    Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
    Moreno P; Lara-Chica M; Soler-Torronteras R; Caro T; Medina M; Álvarez A; Salvatierra Á; Muñoz E; Calzado MA
    PLoS One; 2015; 10(11):e0143376. PubMed ID: 26580787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic role of TPL2 in early‑stage non‑small cell lung cancer.
    Boldrini L; Giordano M; Servadio A; Niccoli C; Bertoglio P; Lucchi M; Melfi F; Mussi A; Fontanini G
    Mol Med Rep; 2017 Jun; 15(6):3451-3458. PubMed ID: 28393206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung Cancer.
    Sacher AG; Dahlberg SE; Heng J; Mach S; Jänne PA; Oxnard GR
    JAMA Oncol; 2016 Mar; 2(3):313-20. PubMed ID: 26720421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
    Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
    J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.
    Kong F; Gao F; Chen J; Sun Y; Zhang Y; Liu H; Li X; Yang P; Zheng R; Liu G; Jia Y
    Oncotarget; 2016 Aug; 7(35):56193-56199. PubMed ID: 27486880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib.
    Su Y; Long X; Song Y; Chen P; Li S; Yang H; Wu P; Wang Y; Bing Z; Cao Z; Cao L; Wu Y; Zhang Z; Liu J; Li B; Xiang J; Ma K; Zhang T; Zhang L; Mao X; Liu H; Xing P; Liang N
    Target Oncol; 2019 Apr; 14(2):159-168. PubMed ID: 30895431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oncogenic lung cancer fusion kinase CD74-ROS activates a novel invasiveness pathway through E-Syt1 phosphorylation.
    Jun HJ; Johnson H; Bronson RT; de Feraudy S; White F; Charest A
    Cancer Res; 2012 Aug; 72(15):3764-74. PubMed ID: 22659450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK.
    Shaw AT; Yeap BY; Mino-Kenudson M; Digumarthy SR; Costa DB; Heist RS; Solomon B; Stubbs H; Admane S; McDermott U; Settleman J; Kobayashi S; Mark EJ; Rodig SJ; Chirieac LR; Kwak EL; Lynch TJ; Iafrate AJ
    J Clin Oncol; 2009 Sep; 27(26):4247-53. PubMed ID: 19667264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
    Gharabaghi MA
    Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of
    Reguart N; Teixidó C; Giménez-Capitán A; Paré L; Galván P; Viteri S; Rodríguez S; Peg V; Aldeguer E; Viñolas N; Remon J; Karachaliou N; Conde E; Lopez-Rios F; Nadal E; Merkelbach-Bruse S; Büttner R; Rosell R; Molina-Vila MA; Prat A
    Clin Chem; 2017 Mar; 63(3):751-760. PubMed ID: 28073897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Effect of MAC30 Expression on Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy.
    Ding H; Gui X; Lin X; Chen R; Ma T; Sheng Y; Cai H; Fen Y
    Technol Cancer Res Treat; 2017 Oct; 16(5):645-653. PubMed ID: 27688262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.
    Sakashita H; Inoue H; Akamine S; Ishida T; Inase N; Shirao K; Mori M; Mimori K
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S590-8. PubMed ID: 23812770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
    Yang H; Gao XY; Li P; Jiang TS
    Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHIP involves in non-small cell lung cancer prognosis through VEGF pathway.
    Tingting Q; Jiao W; Qingfeng W; Yancheng L; Shijun YU; Zhaoqi W; Dongmei S; ShiLong W
    Biomed Pharmacother; 2016 Oct; 83():271-276. PubMed ID: 27392029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.